Bridgewater Associates’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-771
| Closed | -$249K | – | 701 |
|
|
2023
Q4 | $249K | Sell |
771
-15,988
| -95% | -$5.16M | ﹤0.01% | 736 |
|
|
2023
Q3 | $6.01M | Buy |
16,759
+290
| +2% | +$104K | 0.04% | 326 |
|
|
2023
Q2 | $6.24M | Buy |
16,469
+15,666
| +1,951% | +$5.94M | 0.04% | 263 |
|
|
2023
Q1 | $385K | Sell |
803
-11,171
| -93% | -$5.35M | ﹤0.01% | 667 |
|
|
2022
Q4 | $5.03M | Buy |
11,974
+3,563
| +42% | +$1.5M | 0.03% | 358 |
|
|
2022
Q3 | $3.51M | Buy |
8,411
+5,178
| +160% | +$2.16M | 0.02% | 454 |
|
|
2022
Q2 | $1.6M | Buy |
3,233
+2,848
| +740% | +$1.41M | 0.01% | 723 |
|
|
2022
Q1 | $217K | Buy |
+385
| New | +$217K | ﹤0.01% | 958 |
|
|
2019
Q1 | – | Sell |
-6,590
| Closed | -$1.53M | – | 335 |
|
|
2018
Q4 | $1.53M | Buy |
6,590
+4,574
| +227% | +$1.06M | 0.01% | 281 |
|
|
2018
Q3 | $631K | Buy |
2,016
+184
| +10% | +$57.6K | 0.01% | 262 |
|
|
2018
Q2 | $529K | Sell |
1,832
-1,777
| -49% | -$513K | 0.01% | 358 |
|
|
2018
Q1 | $903K | Sell |
3,609
-15,646
| -81% | -$3.91M | 0.01% | 282 |
|
|
2017
Q4 | $4.6M | Buy |
+19,255
| New | +$4.6M | 0.04% | 91 |
|
|
2015
Q4 | – | Sell |
-2,978
| Closed | -$400K | – | 290 |
|
|
2015
Q3 | $400K | Buy |
+2,978
| New | +$400K | 0.01% | 367 |
|